Internal Medicine, Endocrinology, Diabetes, & Metabolism · Hattiesburg, MS
NPI
1316394448
Since 2016
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
5909 U S Highway 49 Ste 30
Hattiesburg, MS, 39402
Phone (601) 296-2780
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
1,774 services
Medicare patients, 2024
418
Average age 71
Drug cost, 2024
$2.0M
5,285 prescriptions
Company payments, 2025
$897
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jaya Naran was code 99214 (office e&m - established), 485 times for 300 patients. In total Jaya Naran billed 1,774 services in 8 codes, and Medicare paid $82K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 485 | 300 | $80.02 | $39K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 475 | 287 | $11.25 | $5,343 |
| 36415 Venipuncture Blood Collection | Office | 322 | 222 | $8.45 | $2,720 |
| 99215 Office E&M - Established | Office | 199 | 175 | $111.16 | $22K |
| 95251 Test - Miscellaneous | Office | 156 | 81 | $23.75 | $3,705 |
| 99204 Office E&M - New | Office | 86 | 86 | $101.43 | $8,723 |
| 82310 Clinical Chemistry | Office | 50 | 32 | $5.06 | $253 |
By year: 2023 $59K for 1,031 services; 2024 $82K for 1,774 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 322 | 222 | $8.45 | $2,720 |
| 82310 Clinical Chemistry | 50 | 32 | $5.06 | $253 |
Medicare prescription drug claims, 2024
In 2024, the drug Jaya Naran prescribed most often to Medicare patients was Levothyroxine Sodium, with 496 prescriptions and refills. In total Jaya Naran wrote 5,285 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 496 | 943 | 122 | $3,727 |
| Ozempic Semaglutide | 303 | 407 | 59 | $375K |
| Jardiance Empagliflozin | 273 | 487 | 70 | $269K |
| Glimepiride Generic | 234 | 541 | 78 | $1,532 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 223 | 445 | 91 | $21K |
| Metformin Hcl Generic | 214 | 524 | 62 | $1,569 |
| Novolog Flexpen Insulin Aspart | 202 | 310 | 67 | $47K |
| Synthroid Levothyroxine Sodium | 189 | 375 | 47 | $14K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 185 | 343 | 58 | $22K |
| Methimazole Generic | 158 | 332 | 45 | $1,274 |
| Tresiba Flextouch U-200 Insulin Degludec | 110 | 216 | 31 | $116K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 106 | 161 | 22 | $77K |
| Mounjaro Tirzepatide | 100 | 135 | 27 | $137K |
| Tresiba Flextouch U-100 Insulin Degludec | 99 | 224 | 36 | $59K |
| Atorvastatin Calcium Generic | 98 | 233 | 33 | $945 |
Brand drugs: 2,942 claims; generic drugs: 1,793 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jaya Naran $897 ($897 in general payments such as food, travel and fees) from 16 companies. The largest payer was Amgen Inc. with $191.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 13 | $191 |
| Sequel Med Tech, LLC | 5 | $102 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $84.69 |
| Novo Nordisk Inc NVO | 4 | $75.28 |
| Insulet Corporation PODD | 3 | $70.48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $58.82 |
| Lilly USA, LLC LLY | 3 | $55.23 |
| Averitas Pharma Inc. | 2 | $50.77 |
| RGH Enterprises LLC | 1 | $40.08 |
| Dexcom, Inc. DXCM | 2 | $39.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.